Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients
Ibrahim Aldoss, Corinna La Rosa, Lindsey R. Baden, et al.
Annals of Internal Medicine (2020) Vol. 172, Iss. 5, pp. 306-306
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Safety and Immunogenicity of a Messenger RNA–Based Cytomegalovirus Vaccine in Healthy Adults: Results From a Phase 1 Randomized Clinical Trial
Carlos Fierro, Daniel C. Brune, Marian Shaw, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 3, pp. e668-e678
Open Access | Times Cited: 18
The Status of Vaccine Development Against the Human Cytomegalovirus
Stanley A. Plotkin, Dai Wang, Abdel Oualim, et al.
The Journal of Infectious Diseases (2019) Vol. 221, Iss. Supplement_1, pp. S113-S122
Open Access | Times Cited: 95
Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform
Flavia Chiuppesi, Marcela D Salazar, Heidi Contreras, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 94
American Society for Transplantation and Cellular Therapy Series: #3—Prevention of Cytomegalovirus Infection and Disease After Hematopoietic Cell Transplantation
Morgan Hakki, Samuel L Aitken, Lara Danziger‐Isakov, et al.
Transplantation and Cellular Therapy (2021) Vol. 27, Iss. 9, pp. 707-719
Open Access | Times Cited: 88
Progress and Challenges in the Prevention, Diagnosis, and Management of Cytomegalovirus Infection in Transplantation
Ajit P. Limaye, Tara M. Babu, Michael Boeckh
Clinical Microbiology Reviews (2020) Vol. 34, Iss. 1
Open Access | Times Cited: 84
Stress-Induced Epstein-Barr Virus Reactivation
Daniel Sausen, Maimoona Bhutta, Elisa Gallo, et al.
Biomolecules (2021) Vol. 11, Iss. 9, pp. 1380-1380
Open Access | Times Cited: 70
40 Years after the Registration of Acyclovir: Do We Need New Anti-Herpetic Drugs?
Anna Majewska, Beata Młynarczyk-Bonikowska
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3431-3431
Open Access | Times Cited: 67
Development of a Vaccine against Human Cytomegalovirus: Advances, Barriers, and Implications for the Clinical Practice
Sara Scarpini, Francesca Morigi, Ludovica Betti, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 551-551
Open Access | Times Cited: 63
Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates
Flavia Chiuppesi, Vu H. Nguyen, Yoonsuh Park, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 51
Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial
Flavia Chiuppesi, John A. Zaia, Paul Frankel, et al.
The Lancet Microbe (2022) Vol. 3, Iss. 4, pp. e252-e264
Open Access | Times Cited: 44
Therapeutic vaccines for herpesviruses
Jeffrey I. Cohen
Journal of Clinical Investigation (2024) Vol. 134, Iss. 9
Open Access | Times Cited: 13
A vaccine against cytomegalovirus: how close are we?
Sallie R. Permar, Mark R. Schleiss, S. A. Plotkin
Journal of Clinical Investigation (2025) Vol. 135, Iss. 1
Closed Access | Times Cited: 1
The Fourth International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation
Camille N. Kotton, Deepali Kumar, Isabel Oriol, et al.
Transplantation (2025)
Closed Access | Times Cited: 1
Viruses as tools in gene therapy, vaccine development, and cancer treatment
Musab bin Umair, Nao Akusa Fujimura, Hadia Kashif, et al.
Archives of Virology (2022) Vol. 167, Iss. 6, pp. 1387-1404
Open Access | Times Cited: 32
Genetic Predisposition of Anti-Cytomegalovirus Immunoglobulin G Levels and the Risk of 9 Cardiovascular Diseases
Jiang-Shan Tan, Jiameng Ren, Luyun Fan, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 27
Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications
Olga V. Orlova, Д. В. Глазкова, E. V. Bogoslovskaya, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1516-1516
Open Access | Times Cited: 21
Proceedings of the Conference “CMV Vaccine Development—How Close Are We?” (27–28 September 2023)
Mark R. Schleiss, Chelsea M. Crooks, Krithika P. Karthigeyan, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1231-1231
Open Access | Times Cited: 4
Safety, Immunogenicity, and Efficacy of Cytomegalovirus Vaccines: A Systematic Review of Randomized Controlled Trials
Manuela Chiavarini, A Genga, G. Ricciotti, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 85-85
Open Access
Developing a Vaccine Against Human Cytomegalovirus: Identifying and Targeting HCMV’s Immunological Achilles’ Heel
Anastasia Lankina, Marta Brezmes Raposo, Alexander Hargreaves, et al.
Vaccines (2025) Vol. 13, Iss. 5, pp. 435-435
Open Access
Towards Precision Vaccines: Lessons From the Second International Precision Vaccines Conference
Dheeraj Soni, Simon D. van Haren, Olubukola T. Idoko, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 25
Large-scale manufacturing and characterization of CMV-CD19CAR T cells
Xiuli Wang, Ryan Urak, Miriam Walter, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 1, pp. e003461-e003461
Open Access | Times Cited: 15
Immunization of Solid Organ Transplant Candidates and Recipients
Hannah Bahakel, Amy G. Feldman, Lara Danziger‐Isakov
Infectious Disease Clinics of North America (2023) Vol. 37, Iss. 3, pp. 427-441
Closed Access | Times Cited: 8
Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management: A report from the CMV International Symposium 2023
Camille N. Kotton, Julián Torre‐Cisneros, Ibrahim Yakoub‐Agha
Transplant Infectious Disease (2023) Vol. 26, Iss. 1
Open Access | Times Cited: 8
Immune control of cytomegalovirus reactivation in stem cell transplantation
Mariapia A. Degli‐Esposti, Geoffrey R. Hill
Blood (2021) Vol. 139, Iss. 9, pp. 1277-1288
Open Access | Times Cited: 19
Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus‐specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis
Corinna La Rosa, Ibrahim Aldoss, Yoonsuh Park, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 4, pp. 588-597
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top